Cargando…

Clinical Phenotypes of CDHR1-Associated Retinal Dystrophies

The retinal dystrophy phenotype associated with CDHR1 retinopathy is clinically heterogenous. In this study, we describe the clinical and molecular findings of a retinal dystrophy cohort (10 patients) attributed to autosomal recessive CDHR1 and report novel variants in populations not previously ide...

Descripción completa

Detalles Bibliográficos
Autores principales: Malechka, Volha V., Cukras, Catherine A., Chew, Emily Y., Sergeev, Yuri V., Blain, Delphine, Jeffrey, Brett G., Ullah, Ehsan, Hufnagel, Robert B., Brooks, Brian P., Huryn, Laryssa A., Zein, Wadih M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9140808/
https://www.ncbi.nlm.nih.gov/pubmed/35627310
http://dx.doi.org/10.3390/genes13050925
_version_ 1784715188576976896
author Malechka, Volha V.
Cukras, Catherine A.
Chew, Emily Y.
Sergeev, Yuri V.
Blain, Delphine
Jeffrey, Brett G.
Ullah, Ehsan
Hufnagel, Robert B.
Brooks, Brian P.
Huryn, Laryssa A.
Zein, Wadih M.
author_facet Malechka, Volha V.
Cukras, Catherine A.
Chew, Emily Y.
Sergeev, Yuri V.
Blain, Delphine
Jeffrey, Brett G.
Ullah, Ehsan
Hufnagel, Robert B.
Brooks, Brian P.
Huryn, Laryssa A.
Zein, Wadih M.
author_sort Malechka, Volha V.
collection PubMed
description The retinal dystrophy phenotype associated with CDHR1 retinopathy is clinically heterogenous. In this study, we describe the clinical and molecular findings of a retinal dystrophy cohort (10 patients) attributed to autosomal recessive CDHR1 and report novel variants in populations not previously identified with CDHR1-related retinopathy. Seven patients had evaluations covering at least a three-year period. The mean age of individuals at first symptoms was 36 ± 8.5 years (range 5–45 years). Visual acuity at the last visit ranged from 20/20 to 20/2000 (mean LogMAR 0.8 or 20/125). Three clinical subgroups were identified: rod–cone dystrophy (RCD), cone–rod dystrophy (CRD), and maculopathy. Extinguished scotopic electroretinography responses were noted in the RCD patients. Macular involvement was noted in all patients and documented on color fundus photography, fundus autofluorescence, and optical coherence tomography. Notable asymmetry of the degree of macular atrophy was present in two patients. The possible association between CDHR1 variants and clinical findings was predicted using molecular modeling.
format Online
Article
Text
id pubmed-9140808
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-91408082022-05-28 Clinical Phenotypes of CDHR1-Associated Retinal Dystrophies Malechka, Volha V. Cukras, Catherine A. Chew, Emily Y. Sergeev, Yuri V. Blain, Delphine Jeffrey, Brett G. Ullah, Ehsan Hufnagel, Robert B. Brooks, Brian P. Huryn, Laryssa A. Zein, Wadih M. Genes (Basel) Article The retinal dystrophy phenotype associated with CDHR1 retinopathy is clinically heterogenous. In this study, we describe the clinical and molecular findings of a retinal dystrophy cohort (10 patients) attributed to autosomal recessive CDHR1 and report novel variants in populations not previously identified with CDHR1-related retinopathy. Seven patients had evaluations covering at least a three-year period. The mean age of individuals at first symptoms was 36 ± 8.5 years (range 5–45 years). Visual acuity at the last visit ranged from 20/20 to 20/2000 (mean LogMAR 0.8 or 20/125). Three clinical subgroups were identified: rod–cone dystrophy (RCD), cone–rod dystrophy (CRD), and maculopathy. Extinguished scotopic electroretinography responses were noted in the RCD patients. Macular involvement was noted in all patients and documented on color fundus photography, fundus autofluorescence, and optical coherence tomography. Notable asymmetry of the degree of macular atrophy was present in two patients. The possible association between CDHR1 variants and clinical findings was predicted using molecular modeling. MDPI 2022-05-22 /pmc/articles/PMC9140808/ /pubmed/35627310 http://dx.doi.org/10.3390/genes13050925 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Malechka, Volha V.
Cukras, Catherine A.
Chew, Emily Y.
Sergeev, Yuri V.
Blain, Delphine
Jeffrey, Brett G.
Ullah, Ehsan
Hufnagel, Robert B.
Brooks, Brian P.
Huryn, Laryssa A.
Zein, Wadih M.
Clinical Phenotypes of CDHR1-Associated Retinal Dystrophies
title Clinical Phenotypes of CDHR1-Associated Retinal Dystrophies
title_full Clinical Phenotypes of CDHR1-Associated Retinal Dystrophies
title_fullStr Clinical Phenotypes of CDHR1-Associated Retinal Dystrophies
title_full_unstemmed Clinical Phenotypes of CDHR1-Associated Retinal Dystrophies
title_short Clinical Phenotypes of CDHR1-Associated Retinal Dystrophies
title_sort clinical phenotypes of cdhr1-associated retinal dystrophies
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9140808/
https://www.ncbi.nlm.nih.gov/pubmed/35627310
http://dx.doi.org/10.3390/genes13050925
work_keys_str_mv AT malechkavolhav clinicalphenotypesofcdhr1associatedretinaldystrophies
AT cukrascatherinea clinicalphenotypesofcdhr1associatedretinaldystrophies
AT chewemilyy clinicalphenotypesofcdhr1associatedretinaldystrophies
AT sergeevyuriv clinicalphenotypesofcdhr1associatedretinaldystrophies
AT blaindelphine clinicalphenotypesofcdhr1associatedretinaldystrophies
AT jeffreybrettg clinicalphenotypesofcdhr1associatedretinaldystrophies
AT ullahehsan clinicalphenotypesofcdhr1associatedretinaldystrophies
AT hufnagelrobertb clinicalphenotypesofcdhr1associatedretinaldystrophies
AT brooksbrianp clinicalphenotypesofcdhr1associatedretinaldystrophies
AT hurynlaryssaa clinicalphenotypesofcdhr1associatedretinaldystrophies
AT zeinwadihm clinicalphenotypesofcdhr1associatedretinaldystrophies